Merck Aims For Two Cardiovascular Medication Approvals Next Year – Medical News Today

by admin on August 28, 2012

Merck Aims For Two Cardiovascular Medication Approvals Next Year
Medical News Today
The two drugs are vorapaxar, an experimental drug for acute coronary syndrome chest pain caused by coronary artery disease, and K-524A (tredaptive), for the treatment of HDL (bad cholesterol) to reduce the incidence of vascular events. The company made

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: